≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

Benign neoplasm: Endocrine pancreas

Endpoint Browser

CD2_BENIGN_ENDOCRINE_PANCREAS_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

None

-

2. Check conditions

None

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D13.7&
  • Hospital discharge: ICD-9 — 2117
  • Cause of death: ICD-10 — D13.7&
  • Cause of death: ICD-9 — 2117

2 out of 7 registries used, show all original rules.

-

4. Check minimum number of events

None

-

5. Include endpoints

None

-

6. Filter based on genotype QC (FinnGen only)

None

-

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D13
Name in latin
Neoplasma benignum partis endocrinae pancreatis

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 201 88 113
Unadjusted period prevalence (%) 0.04 0.03 0.05
Median age at first event (years) 63.92 60.64 66.46

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
178
Matched controls
1779
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D13.7
ICD-10 Finland
Benign neoplasm: Endocrine pancreas
+∞
240.8
172
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
142.0
74.1
75
9
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
45.2
34.6
42
12
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
39.1
28.1
35
11
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
33.3
25.5
33
12
JN3BD
NOMESCO Finland
Extensive abdominal CT
9.4
25.4
57
85
WX302
NOMESCO Finland
Thoracal epidural anesthesy
23.4
25.1
36
19
130
Kela drug reimbursment
Malignant tumour
+∞
23.4
22
*
D13.6
ICD-10 Finland
Benign neoplasm: Pancreas
261.9
23.2
23
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
21.0
22.3
33
19
JLC10
NOMESCO Finland
Distal pancreatectomy
236.1
21.0
21
*
JN4BD
NOMESCO Finland
Extensive body CT
13.0
20.6
37
35
JN4CD
NOMESCO Finland
Very extensive body CT
37.3
18.5
23
7
JN4AD
NOMESCO Finland
Body CT examination
15.4
18.2
30
23
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
18.0
17
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
18.0
17
*
XX3DW
NOMESCO Finland
Time consuming IT work
11.3
17.3
33
35
A09AA02
ATC
multienzymes (lipase, protease etc.)
19.6
16.1
24
14
8240/3-C25.9
ICD-O-3
Neuroendocrine tumor, NOS, of pancreas, NOS
+∞
15.9
15
*
C25.4
ICD-10 Finland
Malignant neoplasm: Endocrine pancreas
+∞
15.9
15
*
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
174.4
15.7
16
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.8
15.2
88
363
JN3AD
NOMESCO Finland
Abdominal CT examination
7.6
15.0
36
57
JLC00
NOMESCO Finland
Excision of lesion of pancreas
+∞
14.8
14
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.9
13.8
71
261
WF002
NOMESCO Finland
Radical radiotherapy
+∞
13.7
13
*
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
28.3
13.7
18
7
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
150.8
13.6
14
*
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
31.0
13.2
17
6
A03FA01
ATC
metoclopramide; systemic, rectal
5.2
12.9
43
103
K86.2
ICD-10 Finland
Cyst of pancreas
34.8
12.8
16
5
E16.10
ICD-10 Finland
Hyperinsulinism
+∞
12.6
12
*
D44.8
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement
139.2
12.6
13
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
139.2
12.6
13
*
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
139.2
12.6
13
*
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
29.0
12.3
16
6
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
50.2
12.1
14
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
6.1
11.8
33
64
116
Kela drug reimbursment
Prostate cancer
+∞
11.6
11
*
JLC11
NOMESCO Finland
Laparoscopic distal pancreatectomy
+∞
11.6
11
*
JLC30
NOMESCO Finland
Pancreatoduodenectomy
+∞
11.6
11
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
11.6
11
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.6
11.2
41
108
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
6.7
11.0
28
48
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.9
10.7
98
526
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
10.5
10
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
10.5
10
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
10.5
10
*
H02AB02
ATC
dexamethasone; systemic
20.3
10.4
15
8
A04AA02
ATC
granisetron; systemic, transdermal
105.2
9.5
10
*
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
105.2
9.5
10
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
9.4
9
*
ZXC96
NOMESCO Finland
Robot assisted procedure
+∞
9.4
9
*
L01BC06
ATC
capecitabine; oral
+∞
9.4
9
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
6.6
9.1
23
39
TPH07
NOMESCO Finland
Cathetrisation of artery
4.7
9.0
31
76
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
9.0
8.8
18
22
WX402
NOMESCO Finland
General anaesthesia
3.8
8.7
38
117
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.8
8.7
67
312
L02AE02
ATC
leuprorelin; implant, parenteral
29.1
8.6
11
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.9
8.6
61
267
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
94.2
8.5
9
*
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
+∞
8.4
8
*
JMA10
NOMESCO Finland
Transabdominal total splenectomy
+∞
8.4
8
*
C25.2
ICD-10 Finland
Malignant neoplasm: Tail of pancreas
+∞
8.4
8
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
+∞
8.4
8
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.1
8.0
21
38
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
47.0
7.8
9
*
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
12.6
7.7
13
11
R50.9
ICD-10 Finland
Fever, unspecified
4.0
7.7
31
89
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.9
7.7
32
95
115
Kela drug reimbursment
Breast cancer
+∞
7.3
7
*
E34.0
ICD-10 Finland
Carcinoid syndrome
+∞
7.3
7
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
7.3
7
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
7.3
7
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.0
7.3
44
173
K86.9
ICD-10 Finland
Disease of pancreas, unspecified
31.4
7.2
9
*
A02BC02
ATC
pantoprazole; systemic
2.4
6.8
128
914
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
41.6
6.8
8
*
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
41.6
6.8
8
*
JAH01
NOMESCO Finland
Laparoscopy
9.2
6.7
13
15
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
72.2
6.5
7
*
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
11.6
6.4
11
10
UJF32
NOMESCO Finland
Coloscopy
2.5
6.3
56
275
H01CB03
ATC
lanreotide; parenteral
+∞
6.3
6
*
H01CB02
ATC
octreotide; parenteral
+∞
6.3
6
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
6.3
6
*
V03AH01
ATC
diazoxide; systemic
+∞
6.3
6
*
8249/3-C25.9
ICD-O-3
Neuroendocrine tumor, grade 2 of pancreas, NOS
+∞
6.3
6
*
JN1AD
NOMESCO Finland
CT examination of upper part of abdomen
27.7
6.3
8
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.8
6.2
41
170
UJK02
NOMESCO Finland
ERCP
9.1
6.2
12
14

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
80
93
13.63
68.36
3.1
1.5
2.9
5.8
ug/l
0.41
59
67
46
38
15.40
47.88
2.3
1.8
34.5
10.7
u/ml
0.49
40
26
48
47
13.10
44.90
1.6
1.3
—
—
—
0
0
37
41
10.83
31.37
1.8
1.2
229.1
299.6
ug/g
0.87
28
24
151
710
5.53
27.21
8.0
5.1
1.2
1.2
mmol/l
0.14
143
643
124
522
4.59
25.23
3.7
2.2
60.5
57.8
u/l
0.19
118
483
144
683
4.91
24.81
7.3
3.6
34.6
35.7
g/l
1.58
139
639
155
791
5.19
23.89
11.0
5.6
1.2
1.2
mmol/l
0.02
121
688
113
459
4.34
23.79
4.8
3.4
7.4
7.4
ph
0.18
31
77
139
680
4.38
22.00
15.3
10.6
1.3
1.3
inr
0.40
53
190
54
149
4.59
18.56
2.7
1.8
304.7
30.6
u/l
0.55
46
122
48
127
4.65
17.31
4.6
4.1
89.0
85.4
ng/l
0.11
41
107
87
362
3.47
16.35
4.0
3.2
91.9
89.4
%
0.36
87
354
19
22
9.43
15.26
1.6
1.3
—
—
—
0
0
102
486
3.23
15.06
2.4
1.6
—
—
—
0
0
43
117
4.40
14.84
4.4
3.0
1.2
1.2
mmol/l
0.08
36
103
158
983
3.84
14.76
8.0
4.1
7.0
6.9
mmol/l
0.25
152
906
19
23
9.02
14.75
1.4
1.3
—
—
nmol/l
—
0
0
64
233
3.56
14.62
3.1
2.5
0.8
0.8
mmol/l
0.95
64
216
123
687
3.04
13.20
5.6
3.7
—
—
—
0
0
40
116
4.06
12.59
1.6
1.1
—
—
—
0
0
92
451
2.92
12.35
3.2
2.7
1.5
0.5
e6/l
0.32
71
326
89
437
2.86
11.80
3.3
2.7
—
—
—
0
0
48
172
3.35
10.97
2.5
2.3
9.6
7.1
umol/l
0.39
41
151
54
210
3.15
10.77
6.9
5.3
106.4
104.2
mmol/l
3.44
54
202
94
496
2.68
10.58
3.4
3.0
215.0
61.5
e6/l
0.46
72
371
12
13
9.75
9.97
1.3
1.2
—
—
—
0
0
12
13
9.75
9.97
2.3
1.3
—
—
—
0
0
49
189
3.11
9.84
8.2
6.1
5.1
5.2
kpa
0.10
49
183
86
452
2.58
9.55
2.9
2.1
—
—
—
0
0
38
129
3.40
9.38
4.8
3.6
—
—
—
0
0
48
189
3.02
9.27
8.3
6.1
14.0
11.5
kpa
2.02
48
184
151
1062
2.70
8.65
4.9
4.2
—
3619.4
—
0
21
90
501
2.44
8.65
4.7
2.1
2.4
2.3
mmol/l
1.21
84
422
31
98
3.56
8.51
4.5
4.5
0.0
0.1
%
—
8
19
17
34
5.37
8.30
4.9
3.5
2.8
2.4
mmol/l
0.21
11
18
131
875
2.43
8.18
10.2
6.1
4.5
4.3
e9/l
0.53
118
765
47
199
2.78
7.87
3.0
2.7
21.8
23.9
%
0.35
40
173
98
587
2.31
7.76
4.0
3.5
59.9
102.6
e6/l
0.46
74
409
30
99
3.39
7.69
4.6
4.5
0.8
0.4
%
—
8
17
76
412
2.36
7.55
5.5
3.8
—
—
—
0
0
30
102
3.28
7.33
4.8
4.4
0.1
0.1
%
—
9
21
17
39
4.67
7.11
5.3
3.4
7.4
7.4
ph
0.02
17
33
24
72
3.65
7.09
4.5
3.8
—
—
—
0
0
31
110
3.15
7.06
4.7
4.2
0.8
1.1
%
—
8
24
67
357
2.32
6.82
8.3
4.7
—
—
—
0
0
14
28
5.30
6.81
4.8
3.2
—
—
—
0
0
48
222
2.53
6.67
1.6
1.2
—
—
—
0
0
119
807
2.16
6.57
4.4
3.7
0.0
0.0
estimate
0.00
38
142
119
816
2.12
6.28
4.4
3.7
0.0
0.0
estimate
0.00
36
137
108
719
2.09
6.11
16.2
8.2
0.0
0.0
e9/l
0.03
93
586
117
806
2.08
5.99
5.9
5.1
0.0
0.0
estimate
0.00
36
139
42
194
2.47
5.80
1.4
1.7
—
—
—
0
0
56
300
2.20
5.49
4.1
2.1
2.5
2.4
mmol/l
2.72
50
251
66
380
2.10
5.38
1.3
1.3
—
—
—
0
0
67
392
2.06
5.21
2.4
2.0
3.4
3.1
mg/l
0.43
62
325
90
587
1.97
5.14
3.2
3.2
7.0
7.7
mmol/l
1.06
77
487
46
233
2.26
5.14
2.3
1.9
—
—
—
0
0
35
157
2.49
5.12
1.5
1.3
—
—
—
0
0
154
1212
2.16
5.09
5.4
3.9
—
—
—
0
0
84
539
1.96
5.00
5.6
5.0
—
—
—
0
0
95
636
1.94
4.99
3.9
3.4
—
—
—
0
0
92
611
1.93
4.93
4.2
4.2
8.6
6.3
mg/mmol
0.21
54
378
18
57
3.37
4.90
2.4
1.9
8.8
2.7
ug/l
0.53
18
52
87
570
1.93
4.83
3.1
3.4
59.6
163.2
mg/l
0.42
51
358
10
20
5.21
4.83
3.1
3.4
—
—
—
0
0
8
7
11.83
4.82
3.0
1.1
—
—
—
0
0
112
798
1.91
4.82
5.7
4.9
0.7
0.6
e9/l
0.98
101
689
75
468
1.96
4.81
1.7
1.6
1.5
1.3
mmol/l
0.72
62
388
61
354
2.04
4.80
5.0
3.8
—
—
—
0
0
112
803
1.89
4.68
5.7
4.9
0.0
0.0
e9/l
0.05
101
700
30
131
2.52
4.63
6.5
7.0
—
—
—
0
0
21
76
2.97
4.61
7.8
8.4
23.2
24.9
mmol/l
1.39
21
68
112
812
1.86
4.43
5.7
5.0
1.9
1.9
e9/l
0.02
102
718
113
822
1.86
4.42
5.7
5.1
0.2
0.2
e9/l
0.07
102
726
100
702
1.84
4.37
4.4
3.8
39.7
45.8
ng/l
0.18
76
512
12
31
4.05
4.32
4.6
2.9
52.5
58.2
%
0.59
12
31
70
441
1.90
4.28
4.9
3.8
0.0
0.0
estimate
0.00
32
138
155
1256
2.02
4.27
4.4
3.7
15.0
15.0
pmol/l
0.02
143
1129
72
462
1.87
4.14
3.6
3.1
—
—
—
0
0
8
10
8.27
4.10
4.0
1.4
15.2
12.3
ug/l
—
8
10
17
59
3.06
4.01
2.8
1.8
—
—
—
0
0
188
1660
3.05
4.01
25.0
12.4
33.1
23.5
mg/l
2.18
175
1276
69
442
1.85
3.96
4.1
3.3
—
—
—
0
0
21
83
2.71
3.94
12.7
8.3
—
—
—
0
0
143
1147
1.86
3.81
4.8
3.9
—
—
—
0
0
11
30
3.82
3.69
3.6
2.3
3.5
4.6
e9/l
1.09
11
30
66
428
1.81
3.59
1.5
1.5
21.1
22.2
nmol/l
0.26
59
365
69
455
1.79
3.55
2.3
2.6
390.5
8988.3
umol/l
2.44
54
400
78
535
1.75
3.49
2.0
2.1
177.6
179.7
u/l
0.01
72
498
25
117
2.30
3.33
11.8
6.0
25.0
24.9
mmol/l
0.04
25
112
6
7
8.79
3.28
2.7
1.1
26.7
27.7
umol/l
—
6
7
59
381
1.78
3.22
2.1
1.7
454.8
416.2
pmol/l
0.62
46
309
91
665
1.67
3.16
3.3
2.7
164.4
119.2
ug/l
0.70
85
607
52
325
1.81
3.15
2.5
1.8
1315.2
1238.1
nmol/l
0.22
43
251
29
149
2.11
3.09
2.9
2.4
60.6
66.6
e9/l
0.48
24
111
10
29
3.58
3.09
4.4
2.7
—
—
—
0
0
25
121
2.22
3.08
8.9
4.2
—
—
—
0
0
188
1701
2.63
3.03
6.5
4.8
6.5
6.1
mmol/l
2.14
181
1533
176
1557
2.05
2.90
5.2
4.5
1.9
1.9
mu/l
0.13
162
1401
182
1636
2.19
2.77
8.9
6.5
41.8
40.6
mmol/mol
0.89
176
1520
7
15
4.79
2.62
2.6
1.5
135.7
249.6
u/ml
—
7
15
191
1759
2.73
2.62
32.3
15.3
4.0
4.0
mmol/l
0.77
191
1706
191
1760
2.71
2.59
32.4
15.1
139.6
139.8
mmol/l
0.33
191
1707
148
1261
1.66
2.55
4.6
4.1
13.0
11.4
mm/h
0.64
135
1149
22
111
2.10
2.47
1.5
1.3
—
—
—
0
0
14
58
2.52
2.43
5.2
3.4
3.8
3.9
mmol/l
0.18
14
52
12
46
2.71
2.40
2.0
1.3
32.2
32.6
mg/l
—
7
37
12
46
2.71
2.40
2.0
1.3
38.2
47.1
mg/l
—
7
36
190
1756
2.50
2.38
25.9
12.2
—
—
—
0
0
192
1798
2.51
2.37
31.7
14.6
86.4
80.5
umol/l
0.90
192
1798
53
361
1.64
2.32
1.6
1.8
2.4
1.0
mg/l
0.95
41
277
18
86
2.20
2.31
1.3
1.3
—
—
—
0
0
9
29
3.20
2.25
2.1
1.2
—
—
—
0
0
55
382
1.61
2.22
4.2
3.5
—
—
—
0
0
44
291
1.66
2.15
1.4
1.3
2.4
2.7
g/l
0.73
27
164
50
344
1.60
2.09
1.3
1.3
0.9
1.4
u/ml
0.68
12
93
5
10
5.10
2.08
1.6
1.2
—
—
—
0
0
71
532
1.52
2.04
4.7
4.0
—
—
—
0
0
8
28
2.93
1.88
2.0
2.7
—
—
—
0
0
29
181
1.70
1.75
1.6
1.6
—
—
—
0
0
16
83
2.01
1.70
1.4
1.3
1.0
1.2
g/l
0.19
16
75
7
25
2.86
1.66
1.9
2.0
31.1
34.0
pg
—
7
25
7
27
2.65
1.53
1.1
1.4
—
—
—
0
0
90
742
1.39
1.47
2.3
1.9
91.1
95.0
pmol/l
0.39
53
378
6
22
2.78
1.44
1.2
1.2
—
—
—
0
0
164
1502
1.50
1.41
22.9
13.4
39.2
40.4
%
0.62
96
1030
5
17
2.99
1.36
1.0
1.1
—
—
—
0
0
30
212
1.49
1.12
1.4
1.3
506.7
623.5
titre
—
6
46
5
21
2.41
1.09
1.8
1.4
93.6
90.0
%
—
5
21
7
32
2.23
1.09
4.0
3.1
—
—
—
0
0
11
60
1.88
1.05
1.9
2.0
—
—
—
0
0
45
349
1.37
1.03
5.3
3.8
323.3
221.9
ng/l
0.23
38
281
25
177
1.47
0.94
4.5
3.4
—
—
—
0
0
6
29
2.10
0.90
2.2
2.1
—
—
—
0
0
130
1407
0.78
0.86
34.0
16.2
332.6
332.9
g/l
0.12
130
1401
8
45
1.81
0.85
1.1
1.1
—
—
—
0
0
6
33
1.84
0.79
2.3
2.2
—
—
—
0
0
26
193
1.40
0.78
1.3
1.4
—
—
—
0
0
50
412
1.28
0.76
3.8
2.7
0.9
0.8
ug/l
0.36
41
272
22
159
1.43
0.76
1.5
1.4
—
—
—
0
0
20
142
1.45
0.76
4.1
3.0
—
—
—
0
0
23
168
1.42
0.75
3.8
3.4
2.2
2.4
mmol/l
0.10
18
131
15
102
1.51
0.70
2.5
2.4
—
—
—
0
0
5
28
1.81
0.66
3.0
2.5
—
—
—
0
0
192
1872
1.57
0.63
39.7
18.4
131.6
137.6
g/l
5.74
192
1838
192
1872
1.57
0.63
39.4
18.3
4.4
4.5
e12/l
3.93
192
1811
192
1872
1.57
0.63
39.4
18.3
6.9
6.7
e9/l
1.14
192
1814
192
1871
1.58
0.63
39.3
18.2
30.3
30.4
pg
0.82
192
1838
192
1871
1.58
0.63
39.3
18.3
91.4
91.3
fl
0.16
192
1839
84
749
1.21
0.63
6.2
4.0
2.3
2.0
ug/l
0.28
76
669
192
1870
1.60
0.63
39.4
18.3
243.9
241.6
e9/l
0.19
192
1820
5
30
1.68
0.62
3.0
2.4
108.0
105.0
mmol/l
—
5
30
5
30
1.68
0.62
3.0
2.4
4.1
4.1
mmol/l
—
5
30
0
21
0.00
0.60
0.0
1.0
—
11.9
—
0
12
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
0
22
0.00
0.59
0.0
1.3
—
59.8
—
0
7
0
22
0.00
0.59
0.0
1.0
—
0.2
—
0
5
13
89
1.49
0.59
4.8
3.6
—
—
—
0
0
22
283
0.75
0.58
1.0
1.3
1.4
10.0
u/ml
1.94
12
101
9
64
1.43
0.52
1.6
1.3
—
—
—
0
0
18
136
1.36
0.51
1.2
1.5
—
—
—
0
0
7
49
1.44
0.46
1.0
1.2
—
—
—
0
0
19
148
1.31
0.45
2.3
1.4
—
—
—
0
0
10
69
1.47
0.45
1.8
1.4
—
—
—
0
0
12
87
1.40
0.43
2.8
2.2
0.7
0.6
%
0.53
12
87
16
123
1.33
0.42
1.1
1.2
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
2.3
—
0
6
0
18
0.00
0.40
0.0
1.1
—
1.0
—
0
7
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
0
19
0.00
0.39
0.0
2.3
—
—
—
0
0
0
19
0.00
0.39
0.0
1.1
—
1.0
—
0
9
19
152
1.28
0.38
11.3
3.7
—
—
—
0
0
6
42
1.44
0.36
1.8
2.7
—
—
—
0
0
7
52
1.36
0.31
7.1
3.9
—
—
—
0
0
10
75
1.35
0.31
4.5
2.0
379.6
323.7
ug/l
—
10
68
8
106
0.74
0.30
1.9
1.6
—
—
—
0
0
8
109
0.72
0.29
2.1
2.4
4.4
4.1
e9/l
—
8
78
25
214
1.19
0.29
2.2
1.7
—
—
—
0
0
42
378
1.14
0.27
4.9
4.0
1.0
1.0
kg/l
—
9
54
14
113
1.26
0.27
2.9
2.9
—
—
—
0
0
9
75
1.21
0.25
1.1
1.6
—
—
—
0
0
9
75
1.21
0.25
9.7
5.4
24.2
25.4
mmol/l
—
9
70
0
11
0.00
0.21
0.0
2.2
—
—
—
0
0
0
11
0.00
0.21
0.0
3.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.9
—
—
—
0
0
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
5
43
1.17
0.21
1.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
1.8
—
0
13
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
20
174
1.17
0.20
2.3
1.4
—
—
—
0
0
14
118
1.20
0.19
1.1
1.2
—
—
—
0
0
10
81
1.25
0.19
1.2
1.4
—
—
—
0
0
7
63
1.12
0.17
1.0
1.1
—
—
—
0
0
8
73
1.10
0.16
1.4
1.9
1.7
1.5
g/l
—
8
60
59
617
0.94
0.12
3.5
3.2
—
—
—
0
0
28
299
0.93
0.10
1.1
1.3
10.1
33.3
iu/ml
—
7
102
174
1758
0.92
0.10
6.1
5.3
2.5
2.7
mmol/l
2.08
165
1608
10
112
0.89
0.07
1.1
1.5
—
—
—
0
0
172
1713
1.03
0.01
5.3
4.7
1.4
1.4
mmol/l
2.29
164
1564
13
134
0.97
0.00
1.4
1.4
—
—
—
0
0
166
1659
1.00
0.00
4.8
4.2
1.4
1.3
mmol/l
1.22
155
1501
173
1725
1.02
0.00
5.5
4.7
4.3
4.5
mmol/l
2.84
165
1584
10
102
0.98
0.00
1.3
1.1
35.4
193.9
u/ml
—
10
94
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
2.8
—
54.2
—
0
6
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
9
91
0.99
0.00
10.1
4.7
—
—
—
0
0
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
4.6
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
6
61
0.98
0.00
1.8
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
2.2
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_ENDOCRINE_PANCREAS_EXALLC – Benign neoplasm: Endocrine pancreas

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).